Clinicians and patient groups have called on parliament to support a PBS listing for the biologic dupilumab as a breakthrough treatment for atopic dermatitis. And in response to their testimony at inquiry into allergies and anaphylaxis, MPs said they have written to the federal Minister for Health ahead of the Pharmaceutical Benefits Advisory Committee (PBAC) ...
Parliament hears pleas for dupilumab PBS access for eczema patients
By Michael Woodhead
27 Feb 2020